Recruiting

Observational Study

Sponsor:

Wake Forest University Health Sciences

Code:

NCT06795087

Conditions

Genitourinary Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Opioid Medication Disposal Education

Study Details

Brief summary:

The main purpose of this research study is to determine the amount of opioids that are taken after discharge following a cystectomy, nephrectomy (partial or total), or prostatectomy surgeries via a 30-day post- discharge opioid use and disposal survey. We will also evaluate the impact of an opioid disposal education pamphlet on proper disposal of unused opioids.

Conditions

Genitourinary Cancer

Study ID

NCT06795087

Start date

Feb 21, 2025

Status verified date

Jul, 2026

Completion date

Jul, 2027

Anticipated

Primary completion date

Jul, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

1. Written informed consent and HIPAA authorization for release of personal health information.
2. Age ≥ 18 years at the time of enrollment
3. Scheduled to undergo surgical cystectomy, partial or total nephrectomy or prostatectomy for a cancer diagnosis.
4. Ability to read and understand the English and/or Spanish language.
5. As determined by the enrolling investigator, ability of the participant to understand and comply with study procedures for the entire length of the study.

Exclusion Criteria:

  • None

Study Design

Enrollment

684 participants

Anticipated

Interventions and Outcome Measures

Arms

Pre-Education Cohort

Post-Education Cohort

Interventions

Opioid Medication Disposal Education

Education on opioid medication disposal will be provided in the form of a pamphlet created by Atrium Health based on FDA resources and will be given to all participants at the time of consent (cystectomy, nephrectomy, prostatectomy) beginning in the second year, approximately 13 months from when the first participant is enrolled or until a minimum of 100 evaluable participants are enrolled in the pre-education cohort, whichever occurs last.

Primary outcome measure

  • Discharge opioids consumed in 30 days after discharge [ Time Frame: 30 days after discharge ]

Central Contacts and Locations

Central contacts

Margarita Dzhanumova

704-355-2000Margarita.Dzhanumova@advocatehealth.org

Locations

Levine Cancer Institute

Recruiting

Charlotte, North Carolina, United States, 28204

Contacts

Margarita Dzhanumova

704-355-2000Margarita.Dzhanumova@advocatehealth.org

Principal Investigator:

Stephen Riggs, MD

More Information

Sponsor

Wake Forest University Health Sciences

Last update posted

Jul 23, 2026

Last verified

Jul, 2026

Keywords

  • Genitourinary Cancer
  • Cystectomies
  • Nephrectomies
  • Prostatectomies

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Wake Forest University Health Sciences on 2026-07-23.